Table 3. Data of pain at pretreatment and post-treatment.
Pretreatment post-treatment intragroup comparison
ES standardized (90% CL) intragroups Chances QA ES standardized (90% CL) between groups Chances QA
VAS Passive NVFR -0.5 (-0.91;-0.10) 90/10/0 Likely 0.61 (1.37;-0.15) 82/14/4 Likely
VFR -1.22 (-1.93;-0.51) 99/1/0 Very likely
Quadriceps isometric activation NVFR -0.79 (-1.12;-0.46) 100/0/0 Very likely 0.06 (0.44;-0.31) 27/61/12 Unclear
VFR -0.6 (-0.79;-0.4) 100/0/0 Very likely
Squat NVFR -0.77 (-1.04;-0.51) 100/0/0 Very likely 0.11 (0.59;-0.37) 38/48/14 Unclear
VFR -0.95 (-1.37;-0.53) 100/0/0 Very likely
Quadriceps Stretching NVFR -0.97 (-1.27;-0.66) 100/0/0 Very likely -0.34 (0.08;-0.75) 71/27/2 Unclear
VFR -0.73 (-1.07;-0.39) 99/1/0 Very likely
PPT Lateral vastus NVFR 0.23(0.05;0.41) 61/39/0 Possibly 0.21 (-0.05;0.46) 51/48/1 Unclear
VFR 0.41 (0.19;0.63) 95/5/0 Very likely
Rectus femoris NVFR 0.23 (0.07;0.38) 62/38/0 Possibly 0.04 (-0.2;0.28) 14/81/5 Unlikely
VFR 0.35 (0.13;0.56) 87/13/0 Likely
Vastus medialis NVFR 0.24 (0.03;0.45) 63/37/0 Possibly 0.05 (-0.19;0.29) 14/81/4 Unlikely
VFR -0.5 (-0.91;-0.10) 90/10/0 Likely
NVFR, non-vibration foam roller group; VFR, vibration foam roller group; VAS, visual analogic scale; PPT, pressure pain threshold; ES, standardized differences; QA, quality assessments.